246 related articles for article (PubMed ID: 32474086)
1. Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology.
Sun HJ; Wu ZY; Cao L; Zhu MY; Nie XW; Huang DJ; Sun MT; Bian JS
Pharmacol Res; 2020 Sep; 159():104961. PubMed ID: 32474086
[TBL] [Abstract][Full Text] [Related]
2. Nitroxyl (HNO): the Cinderella of the nitric oxide story.
Irvine JC; Ritchie RH; Favaloro JL; Andrews KL; Widdop RE; Kemp-Harper BK
Trends Pharmacol Sci; 2008 Dec; 29(12):601-8. PubMed ID: 18835046
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the chemical biology of nitroxyl (HNO) detection and generation.
Miao Z; King SB
Nitric Oxide; 2016 Jul; 57():1-14. PubMed ID: 27108951
[TBL] [Abstract][Full Text] [Related]
4. Vasoprotective Actions of Nitroxyl (HNO): A Story of Sibling Rivalry.
Kemp-Harper B
J Cardiovasc Pharmacol; 2021 Dec; 78(Suppl 6):S13-S18. PubMed ID: 34840263
[TBL] [Abstract][Full Text] [Related]
5. Beyond H2S and NO interplay: hydrogen sulfide and nitroprusside react directly to give nitroxyl (HNO). A new pharmacological source of HNO.
Filipovic MR; Eberhardt M; Prokopovic V; Mijuskovic A; Orescanin-Dusic Z; Reeh P; Ivanovic-Burmazovic I
J Med Chem; 2013 Feb; 56(4):1499-508. PubMed ID: 23418783
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.
Kemp-Harper BK; Horowitz JD; Ritchie RH
Drugs; 2016 Sep; 76(14):1337-48. PubMed ID: 27566478
[TBL] [Abstract][Full Text] [Related]
7. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm.
Wink DA; Miranda KM; Katori T; Mancardi D; Thomas DD; Ridnour L; Espey MG; Feelisch M; Colton CA; Fukuto JM; Pagliaro P; Kass DA; Paolocci N
Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2264-76. PubMed ID: 12855429
[TBL] [Abstract][Full Text] [Related]
8. Updating NO
Suarez SA; Vargas P; Doctorovich FA
J Inorg Biochem; 2021 Mar; 216():111333. PubMed ID: 33385637
[TBL] [Abstract][Full Text] [Related]
9. Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties.
Shoman ME; Aly OM
Oxid Med Cell Longev; 2016; 2016():4867124. PubMed ID: 26770654
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System.
Nagpure BV; Bian JS
Oxid Med Cell Longev; 2016; 2016():6904327. PubMed ID: 26640616
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases.
Luo W; Gui DD; Yan BJ; Ren Z; Peng LJ; Wei DH; Liu LS; Zhang DW; Jiang ZS
Cardiovasc Drugs Ther; 2020 Feb; 34(1):113-121. PubMed ID: 32090295
[TBL] [Abstract][Full Text] [Related]
12. Nitroxyl as a Potential Theranostic in the Cancer Arena.
Sun HJ; Lee WT; Leng B; Wu ZY; Yang Y; Bian JS
Antioxid Redox Signal; 2020 Feb; 32(5):331-349. PubMed ID: 31617376
[No Abstract] [Full Text] [Related]
13. Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl.
Yong QC; Hu LF; Wang S; Huang D; Bian JS
Cardiovasc Res; 2010 Dec; 88(3):482-91. PubMed ID: 20660605
[TBL] [Abstract][Full Text] [Related]
14. Nitroxyl (HNO): a novel redox signaling molecule.
Kemp-Harper BK
Antioxid Redox Signal; 2011 May; 14(9):1609-13. PubMed ID: 21299468
[TBL] [Abstract][Full Text] [Related]
15. HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-κB and p38 MAPK pathways.
Zhou Y; Wu Z; Cao X; Ding L; Wen Z; Bian JS
Pharmacol Res; 2016 Sep; 111():885-895. PubMed ID: 27507578
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide signalling in cardiovascular health and disease.
Farah C; Michel LYM; Balligand JL
Nat Rev Cardiol; 2018 May; 15(5):292-316. PubMed ID: 29388567
[TBL] [Abstract][Full Text] [Related]
17. A nitroxyl-responsive near-infrared fluorescent chemosensor for visualizing H
Yang M; Fan J; Sun W; Du J; Long S; Shao K; Peng X
Chem Commun (Camb); 2019 Jul; 55(59):8583-8586. PubMed ID: 31274135
[TBL] [Abstract][Full Text] [Related]
18. The emergence of nitroxyl (HNO) as a pharmacological agent.
Switzer CH; Flores-Santana W; Mancardi D; Donzelli S; Basudhar D; Ridnour LA; Miranda KM; Fukuto JM; Paolocci N; Wink DA
Biochim Biophys Acta; 2009 Jul; 1787(7):835-40. PubMed ID: 19426703
[TBL] [Abstract][Full Text] [Related]
19. cGMP Signaling in Cardiovascular Diseases: Linking Genotype and Phenotype.
Dang TA; Schunkert H; Kessler T
J Cardiovasc Pharmacol; 2020 Jun; 75(6):516-525. PubMed ID: 32487847
[TBL] [Abstract][Full Text] [Related]
20. H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway.
Eberhardt M; Dux M; Namer B; Miljkovic J; Cordasic N; Will C; Kichko TI; de la Roche J; Fischer M; Suárez SA; Bikiel D; Dorsch K; Leffler A; Babes A; Lampert A; Lennerz JK; Jacobi J; Martí MA; Doctorovich F; Högestätt ED; Zygmunt PM; Ivanovic-Burmazovic I; Messlinger K; Reeh P; Filipovic MR
Nat Commun; 2014 Jul; 5():4381. PubMed ID: 25023795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
